Efficacy of esomeprazole for treatment of poorly controlled asthma. - Wikidata - wikimedia - TriplyDB

Efficacy of esomeprazole for treatment of poorly controlled asthma.

Efficacy of esomeprazole for treatment of poorly controlled asthma.

http://www.wikidata.org/entity/Q33428499

about

Reflux revisited: advancing the role of pepsin Asthma: clinical expression and molecular mechanisms Update in asthma 2009 Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran Investigation of extraesophageal gastroesophageal reflux disease Bronchial thermoplasty in asthma: current perspectives Obesity in asthma: approaches to treatment Obesity-related asthma in adults.Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.Predictors of asthma exacerbation among patients with poorly controlled asthma despite inhaled corticosteroid treatment.Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial.Insight Into the Relationship Between Gastroesophageal Reflux Disease and Asthma.The sensitivity of acoustic cough recording relative to intraesophageal pressure recording and patient report during reflux testing.Asthma outcomes: exacerbations Modern medical and surgical management of difficult-to-treat GORD.New developments in extraesophageal reflux disease.Treatment of GERD complications (Barrett's, peptic stricture) and extra-oesophageal syndromes.Coexisting chronic conditions associated with mortality and morbidity in adult patients with asthma.Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity.Effect of obesity on asthma phenotype is dependent upon asthma severity.Treatment of GORD: Three decades of progress and disappointments Does obesity produce a distinct asthma phenotype?Symptomatic reflux disease: the present, the past and the future.Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.The effects of concomitant GERD, dyspepsia, and rhinosinusitis on asthma symptoms and FeNO in asthmatic patients taking controller medications.Residential proximity to a major roadway is associated with features of asthma control in children.Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.Recommendation for optimal management of severe refractory asthma.Asthma outcomes: symptoms.Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo-controlled study.Efficacy of omeprazole on cough, pulmonary function and quality of life of patients with sulfur mustard lung injury: A placebo-control, cross-over clinical trial study Republished: symptomatic reflux disease: the present, the past and the future.Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis.Optimal management of severe/refractory asthma.Effects of obstructive sleep apnea and gastroesophageal reflux disease on asthma control in obesity Pharmacotherapy of severe asthma Vocal cord dysfunction in bronchial asthma. A review article.Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness.Unmet Needs in the Treatment of Gastroesophageal Reflux Disease.Diagnostic accuracy of FEV1/forced vital capacity ratio z scores in asthmatic patients

P2860

Q21285006-D5C36B3B-9958-4863-AD50-8B29B838DAF9 Q24597331-67A66614-EE23-4D14-ACB9-49FFBC1481A2 Q24599763-1C4F4FE9-39C9-456E-83FE-457A3497DA83 Q26777154-C74F3B9F-A362-4A11-82E3-69E51F9279AE Q26827755-E8006F9B-204C-4896-BE5D-B9AC9B9B5197 Q26852643-F6056734-51BD-41F1-AB40-F9A02FE365F8 Q27021889-1255B0BD-BAE6-4CC8-97E3-A646E4132C9A Q30249408-81A8AABB-AF53-412A-A4AE-67B00275C12F Q30276073-0F3920C8-1270-4B11-A6AD-90E1BD743991 Q30277850-47C22395-DF4D-407A-A3BF-D0C6EE6960FA Q30352609-FF8B23E1-ED04-4CC1-8FE4-69EBD34E9808 Q30358234-3A19DE50-2AE2-4650-A7AA-03D732E59031 Q30399991-D25382E6-0D62-459F-8DC3-B330B4E02B55 Q30421935-5994887C-9783-4663-BCFE-468D7A347BD0 Q30436969-010D9A5D-8AEA-46D7-A143-17ACB4C97497 Q30457464-0A6C8401-0981-40A5-9241-97FAC39C82D4 Q30472472-FDC0A22A-9E1A-465F-AED1-4958ED4BB737 Q30581306-74E7E533-9F83-4298-9282-AF80C90E6EFF Q33491393-BFC60A79-4EC0-44E0-84F6-875CB7FD5D6D Q33555107-D79FCA85-31C3-491E-8787-77A2F3627C1B Q33695362-B1745360-66BD-45FD-A3CE-0C2B467C1997 Q33728026-CACD0D28-A05F-43FA-A7DC-FE37E57A76A9 Q33834731-F326D3AE-34BC-4B72-9D5D-28C978C3FFF4 Q34127482-D88AE83B-EB97-4F8E-AAC2-AD05C1220070 Q34167415-0B5BCD9C-134B-4B99-93EA-0DC385AD2C7A Q34277666-0D50455B-F515-482B-A47F-2E2FDF4C405A Q34479280-64472379-19FE-4CDC-AB79-C51B8B92F41A Q34620187-F6301B00-4D89-42CF-BDA5-2F4F30C2FD66 Q34677163-B57469A6-F1B4-4937-8855-CE17260FE30B Q34777460-07315ED2-990A-4454-816F-9286D8ED4576 Q35025240-99B426AD-AB63-4000-95E0-ECF0A5F14174 Q35048270-2CC63DF2-51D4-4BEB-A054-2BB7426B66EE Q35094592-0925A60D-F799-4F12-ACEA-16E34393536A Q35193179-A03BCDBB-DB52-4C37-BAC1-DCC013C4BB1E Q35209915-ED6FA430-C144-49C6-BE40-61A199755A01 Q35322603-05C6D26E-4486-428C-9491-64DDE2982490 Q35387321-F552E875-900B-47DC-B2D7-1BA33C56CC9C Q35523534-B5DED9A0-0064-452F-A395-D90B05AEB9BB Q35834504-A1945297-150F-4DCF-A049-C646D804BCAE Q36037447-8CFA6A6E-8605-4D81-AA34-2F0E9AC75BA2

P2860

Efficacy of esomeprazole for treatment of poorly controlled asthma.

http://www.wikidata.org/entity/Q33428499

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Efficacy of esomeprazole for treatment of poorly controlled asthma.

@ast

Efficacy of esomeprazole for treatment of poorly controlled asthma.

@en

type

label

Efficacy of esomeprazole for treatment of poorly controlled asthma.

@ast

Efficacy of esomeprazole for treatment of poorly controlled asthma.

@en

prefLabel

Efficacy of esomeprazole for treatment of poorly controlled asthma.

@ast

Efficacy of esomeprazole for treatment of poorly controlled asthma.

@en

P1433

Q33428499-9E6D6D88-1156-4CE0-8B33-7390B97FC7ED

P1476

Q33428499-3E4D766C-2BD2-4F61-86D4-7A8F02156418

P2093

Q33428499-14FBD39E-B721-4A89-A383-2B2523E63679

Q33428499-73A4688E-66A8-480C-BCD9-C28DA28C99F4

Q33428499-75A9B4FE-6455-48C8-8B0B-AEE121685AB6

Q33428499-BB16FAC1-9EB1-40D4-8CC6-35E7CADD98B6

Q33428499-BBF2087A-3012-42D8-844B-9E8842D6C70C

Q33428499-DB633DC8-6540-4FB0-8416-12D441C033EC

Q33428499-EA627F48-AFD2-40DD-BD77-7DE577AA93BF

P2860

Q33428499-07FDAE42-61D6-4D19-8B63-AFDC3FB92FD4

Q33428499-09F4584C-ECA4-4CA8-B9EC-FF2544BF3CF1

Q33428499-174A9941-1D1A-49C1-AEA1-09BD6815FA8A

Q33428499-230DC51A-5A78-47A0-9917-FC1767EB9AC7

Q33428499-2C1A2AE4-0BB2-491E-82EC-3F8F550A5BD2

Q33428499-4403A52C-8198-49CF-A097-7B88D15FD38A

Q33428499-4CCE7C8D-4B11-4516-A0C2-78D57D4D3175

Q33428499-63BF7CE3-73C4-4356-8807-828B8166509B

Q33428499-7D8B5045-C2BC-426F-8B65-51652D3E5A6A

Q33428499-8CD02A9F-EEBD-407F-8378-67F85712313C

P304

Q33428499-172E1C51-200E-42CD-8353-5B78CAC2920A

P31

Q33428499-2531026A-0E08-4F03-A6A9-5A0835A93940

P356

Q33428499-9C34C7DA-018C-48E2-8B5E-FF76FD6FB863

P407

Q33428499-E7285656-974B-48A8-88CE-4A9A51576302

P433

Q33428499-B23C6B98-47C5-4CC2-972E-C62D5D3E69E8

P478

Q33428499-DD031B79-18EE-44AE-AED8-893B962BDD9B

P50

Q33428499-0F9F3153-0194-4C9A-A845-1EB88154CD2C

P577

Q33428499-0D072A64-BAED-44DE-9C99-A6ACE92A7B03

P698

Q33428499-A16A7B31-6413-474B-8340-F7B7C52CEF8E

P921

Q33428499-84D0D564-BCF9-4077-9900-96EE6755A461

P932

Q33428499-34C6EF63-A084-4BE1-8BA2-F66EF9337F1F

P356

P1433

The New England Journal of Medicine

P1476

Efficacy of esomeprazole for treatment of poorly controlled asthma.

@en

P2093

American Lung Association Asthma Clinical Research Centers

http://www.w3.org/2001/XMLSchema#string

Frank T Leone

http://www.w3.org/2001/XMLSchema#string

Janet T Holbrook

http://www.w3.org/2001/XMLSchema#string

John G Mastronarde

http://www.w3.org/2001/XMLSchema#string

Mario Castro

http://www.w3.org/2001/XMLSchema#string

Nicholas R Anthonisen

http://www.w3.org/2001/XMLSchema#string

W Gerald Teague

http://www.w3.org/2001/XMLSchema#string

P2860

Spirometric reference values from a sample of the general U.S. population

Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease

Gastro-oesophageal reflux treatment for asthma in adults and children

Standardisation of spirometry

Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review.

Reflex mechanisms in gastroesophageal reflux disease and asthma.

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease.

Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS).

Gastroesophageal reflux disease and asthma. Diagnosis and management.

Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux

P304

1487-1499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0806290

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19357404

http://www.w3.org/2001/XMLSchema#string

P921

P932

2974569

http://www.w3.org/2001/XMLSchema#string